달러 표시
Moderna Announces That Its MRNA-1403 Norovirus Vaccine Candidate Did Not Meet Statistical Criteria For Early Success At Phase 3 Interim Analysis; Now Preparing To Enroll An Additional Cohort | 웨이프 WAPE